Orexins/hypocretins and aminergic systems

Acta Physiologica

Volumn 198, Issue 3, 2010, Pages 263-275

  Eriksson, K S ^a   Sergeeva, O A ^a   Haas, H L ^a   Selbach, O ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Acetylcholine; Dopamine; Histamine; Hypocretin; Noradrenaline; Serotonin

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; AMPHETAMINE; ANTIDEPRESSANT AGENT; CATECHOLAMINE; CATION CHANNEL; DOPAMINE TRANSPORTER; DYNORPHIN; GLUTAMIC ACID; HALOPERIDOL; HISTAMINE; HISTAMINE RECEPTOR; MELANIN CONCENTRATING HORMONE; MODAFINIL; NEUROLEPTIC AGENT; OREXIN; OREXIN A; PHENYLEPHRINE; PROTEIN KINASE INHIBITOR; PSYCHOSTIMULANT AGENT; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; THAPSIGARGIN; UNINDEXED DRUG;

ADDICTION; ADRENERGIC SYSTEM; AMINERGIC SYSTEM; ANXIETY; AROUSAL; ATTENTION DEFICIT DISORDER; BEHAVIOR; BRAIN CORTEX; CATAPLEXY; CHOLINERGIC NERVE CELL; COMPULSION; CONFERENCE PAPER; DEGENERATIVE DISEASE; DEPRESSION; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DORSAL RAPHE NUCLEUS; DRUG EFFECT; DRUG TARGETING; FEEDBACK SYSTEM; FOREBRAIN; GROOMING; HIPPOCAMPUS; HORMONE RELEASE; HUMAN; HYPERACTIVITY; LOCUS CERULEUS; MASTICATION; MEMORY; MIGRAINE; MOOD DISORDER; MOTIVATION; MOTOR DYSFUNCTION; NARCOLEPSY; NERVE CELL; NERVE CELL PLASTICITY; NONHUMAN; NORADRENERGIC SYSTEM; OBESITY; PAIN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN FUNCTION; PSYCHOSIS; RECEPTOR DOWN REGULATION; REM SLEEP; REWARD; SATIETY; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; SLEEP DISORDER; SLEEP WAKING CYCLE; STRESS; SUBSTANTIA NIGRA; TEGMENTUM;

ANIMALS; BEHAVIOR; BIOGENIC AMINES; BRAIN; CEREBRAL CORTEX; CIRCADIAN RHYTHM; ENERGY METABOLISM; ENVIRONMENT; HOMEOSTASIS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMORY; NEURONAL PLASTICITY; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; SLEEP; WAKEFULNESS;

EID: 75749127400     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2009.02015.x     Document Type: Conference Paper

References (99)

1. Acuna-Goycolea, C., Li, Y. van den Pol, A.N. 2004. Group III metabotropic glutamate receptors maintain tonic inhibition of excitatory synaptic input to hypocretin/orexin neurons. J Neurosci 24, 3013 3022.
2. Aou, S., Li, X.L., Li, A.J., Oomura, Y., Shiraishi, T., Sasaki, K., Imamura, T. Wayner, M.J. 2003. Orexin-A (hypocretin-1) impairs Morris water maze performance and CA1-Schaffer collateral long-term potentiation in rats. Neuroscience 119, 1221 1228.
3. Bartsch, T., Levy, M.J., Knight, Y.E. Goadsby, P.J. 2004. Differential modulation of nociceptive dural input to (hypocretin) orexin-A and -B receptor activation in the posterior hypothalamic area. Pain 109, 367 378.
4. Bayer, L., Serafin, M., Eggermann, E., Saint-Mleux, B., Machard, D., Jones, B.E. Muhlethaler, M. 2004. Exclusive postsynaptic action of hypocretin-orexin on sublayer 6b cortical neurons. J Neurosci 24, 6760 6764.
5. Bayer, L., Eggermann, E., Serafin, M., Grivel, J., Machard, D., Muhlethaler, M. Jones, B.E. 2005. Opposite effects of noradrenaline and acetylcholine upon hypocretin/orexin versus melanin concentrating hormone neurons in rat hypothalamic slices. Neuroscience 130, 807 811.
6. Borgland, S.L., Taha, S.A., Sarti, F., Fields, H.L. Bonci, A. 2006. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49, 589 601.
7. Bourgin, P., Huitron-Resendiz, S., Spier, A.D., Fabre, V., Morte, B., Criado, J.R., Sutcliffe, J.G., Henriksen, S.J. de Lecea, L. 2000. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J Neurosci 20, 7760 7765.
8. Brown, R.E., Sergeeva, O.A., Eriksson, K.S. Haas, H.L. 2002. Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J Neurosci 22, 8850 8859.
9. Burdakov, D. Gonzalez, J.A. 2009. Physiological functions of glucose-inhibited neurones. Acta Physiol (Oxf) 195, 71 78.
10. Burdakov, D., Liss, B. Ashcroft, F.M. 2003. Orexin excites GABAergic neurons of the arcuate nucleus by activating the sodium-calcium exchanger. J Neurosci 23, 4951 4957.
11. Burlet, S., Tyler, C.J. Leonard, C.S. 2002. Direct and indirect excitation of laterodorsal tegmental neurons by Hypocretin/orexin peptides: implications for wakefulness and narcolepsy. J Neurosci 22, 2862 2872.
12. Carter, M.E., Borg, J.S. de Lecea, L. 2009. The brain hypocretins and their receptors: mediators of allostatic arousal. Curr Opin Pharmacol 9, 39 45.
13. Chemelli, R.M., Willie, J.T., Sinton, C.M., Elmquist, J.K., Scammell, T., Lee, C., Richardson, J.A., Williams, S.C., Xiong, Y., Kisanuki, Y., Fitch, T.E., Nakazato, M., Hammer, R.E., Saper, C.B. Yanagisawa, M. 1999. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 437 451.
14. Date, Y., Ueta, Y., Yamashita, H., Yamaguchi, H., Matsukura, S., Kangawa, K., Sakurai, T., Yanagisawa, M. Nakazato, M. 1999. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci USA 96, 748 753.
15. Deutch, A.Y. Bubser, M. 2007. The orexins/hypocretins and schizophrenia. Schizophr Bull 33, 1277 1283.
16. Drouot, X., Moutereau, S., Nguyen, J.P., Lefaucheur, J.P., Creange, A., Remy, P., Goldenberg, F. d'Ortho, M.P. 2003. Low levels of ventricular CSF orexin/hypocretin in advanced PD. Neurology 61, 540 543.
17. Duxon, M.S., Stretton, J., Starr, K., Jones, D.N., Holland, V., Riley, G., Jerman, J., Brough, S., Smart, D., Johns, A., Chan, W., Porter, R.A. Upton, N. 2001. Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX1) receptors, with downstream 5-HT2C receptor involvement. Psychopharmacology (Berl) 153, 203 209.
18. Eggermann, E., Serafin, M., Bayer, L., Machard, D., Saint-Mleux, B., Jones, B.E. Muhlethaler, M. 2001. Orexins/hypocretins excite basal forebrain cholinergic neurones. Neuroscience 108, 177 181.
19. Eggermann, E., Bayer, L., Serafin, M., Saint-Mleux, B., Bernheim, L., Machard, D., Jones, B.E. Muhlethaler, M. 2003. The wake-promoting hypocretin-orexin neurons are in an intrinsic state of membrane depolarization. J Neurosci 23, 1557 1562.
20. Eriksson, K.S., Sergeeva, O., Brown, R.E. Haas, H.L. 2001. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 21, 9273 9279. (Pubitemid 33096871)
21. Eriksson, K.S., Sergeeva, O.A., Selbach, O. Haas, H.L. 2004. Orexin (hypocretin)/dynorphin neurons control GABAergic inputs to tuberomammillary neurons. Eur J Neurosci 19, 1278 1284.
22. Fadel, J., Bubser, M. Deutch, A.Y. 2002. Differential activation of orexin neurons by antipsychotic drugs associated with weight gain. J Neurosci 22, 6742 6746.
23. Gerashchenko, D., Salin-Pascual, R. Shiromani, P.J. 2001. Effects of hypocretin-saporin injections into the medial septum on sleep and hippocampal theta. Brain Res 913, 106 115.
24. Gonzalez, J.A., Horjales-Araujo, E., Fugger, L., Broberger, C. Burdakov, D. 2009. Stimulation of orexin/hypocretin neurones by thyrotropin-releasing hormone. J.Physiol 587, 1179 1186.
25. Grivel, J., Cvetkovic, V., Bayer, L., Machard, D., Tobler, I., Muhlethaler, M. Serafin, M. 2005. The wake-promoting hypocretin/orexin neurons change their response to noradrenaline after sleep deprivation. J Neurosci 25, 4127 4130.
26. Haas, H. Panula, P. 2003. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 4, 121 130.
27. Haas, H.L. Selbach, O. 2000. Functions of neuronal adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 362, 375 381.
28. Haas, H.L., Sergeeva, O.A. Selbach, O. 2008. Histamine in the nervous system. Physiol Rev 88, 1183 1241.
29. Hagan, J.J., Leslie, R.A., Patel, S., Evans, M.L., Wattam, T.A., Holmes, S., Benham, C.D., Taylor, S.G., Routledge, C., Hemmati, P. et al. 1999. Orexin-A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 96, 10911 10916.
30. Hara, J., Gerashchenko, D., Wisor, J.P., Sakurai, T., Xie, X. Kilduff, T.S. 2009. Thyrotropin-releasing hormone increases behavioral arousal through modulation of hypocretin/orexin neurons. J Neurosci 29, 3705 3714.
31. Harris, G.C. Aston-Jones, G. 2006. Arousal and reward: a dichotomy in orexin function. Trends Neurosci 29, 571 577.
32. Hirota, K., Kushikata, T., Kudo, M., Kudo, T., Lambert, D.G. Matsuki, A. 2001. Orexin-A and -B evoke noradrenaline release from rat cerebrocortical slices. Br J Pharmacol 134, 1461 1466.
33. Hobson, J.A. Pace-Schott, E.F. 2002. The cognitive neuroscience of sleep: neuronal systems, consciousness and learning. Nat Rev Neurosci 3, 679 693.
34. Horvath, T.L. Gao, X.B. 2005. Input organization and plasticity of hypocretin neurons: possible clues to obesity's association with insomnia. Cell Metab 1, 279 286.
35. Horvath, T.L., Peyron, C., Diano, S., Ivanov, A., Aston-Jones, G., Kilduff, T.S. van den Pol, A.N. 1999. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J Comp Neurol 415, 145 159.
36. Hsueh, Y.C., Cheng, S.M. Pan, J.T. 2002. Fasting stimulates tuberoinfundibular dopaminergic neuronal activity and inhibits prolactin secretion in oestrogen-primed ovariectomized rats: involvement of orexin-A and neuropeptide Y. J Neuroendocrinol 14, 745 752.
37. Huang, Z.L., Urade, Y. Hayaishi, O. 2007. Prostaglandins and adenosine in the regulation of sleep and wakefulness. Curr Opin Pharmacol 7, 33 38.
38. Inoue, I., Yanai, K., Kitamura, D., Taniuchi, I., Kobayashi, T., Niimura, K., Watanabe, T. Watanabe, T. 1996. Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors. Proc Natl Acad Sci USA 93 13316 13320.
39. Jaeger, L.B., Farr, S.A., Banks, W.A. Morley, J.E. 2002. Effects of orexin-A on memory processing. Peptides 23, 1683 1688.
40. Kayaba, Y., Nakamura, A., Kasuya, Y., Ohuchi, T., Yanagisawa, M., Komuro, I., Fukuda, Y. Kuwaki, T. 2003. Attenuated defense response and low basal blood pressure in orexin knockout mice. Am J Physiol Regul Integr Comp Physiol 285, R581 R593.
41. Korotkova, T.M., Eriksson, K.S., Haas, H.L. Brown, R.E. 2002. Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro. Regul Pept 104, 83 89.
42. Korotkova, T.M., Sergeeva, O.A., Eriksson, K.S., Haas, H.L. Brown, R.E. 2003. Excitation of ventral tegmental area dopaminergic and non-dopaminergic neurons by orexins/hypocretins. J Neurosci 23, 7 11.
43. Kukkonen, J.P., Holmqvist, T., Ammoun, S. Akerman, K.E. 2002. Functions of the orexinergic/hypocretinergic system. Am J Physiol Cell Physiol 283, C1567 C1591.
44. Lambe, E.K., Liu, R.J. Aghajanian, G.K. 2007. Schizophrenia, hypocretin (orexin), and the thalamocortical activating system. Schizophr Bull 33, 1284 1290.
45. de Lecea, L., Jones, B.E., Boutrel, B., Borgland, S.L., Nishino, S., Bubser, M. DiLeone, R. 2006. Addiction and arousal: alternative roles of hypothalamic peptides. J Neurosci 26, 10372 10375.
46. Li, Y., Gao, X.B., Sakurai, T. van den Pol, A.N. 2002. Hypocretin/Orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system. Neuron 36, 1169 1181.
47. Lin, J.S., Hou, Y., Sakai, K. Jouvet, M. 1996. Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. J Neurosci 16, 1523 1537.
48. Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P.J., Nishino, S. Mignot, E. 1999. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 365 376.
49. Lin, L., Wisor, J., Shiba, T., Taheri, S., Yanai, K., Wurts, S., Lin, X., Vitaterna, M., Takahashi, J., Lovenberg, T.W., Koehl, M., Uhl, G., Nishino, S. Mignot, E. 2002. Measurement of hypocretin/orexin content in the mouse brain using an enzyme immunoassay: the effect of circadian time, age and genetic background. Peptides 23, 2203 2211.
50. Liu, R.J., van den Pol, A.N. Aghajanian, G.K. 2002. Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J Neurosci 22, 9453 9464.
51. Lutter, M., Krishnan, V., Russo, S.J., Jung, S., McClung, C.A. Nestler, E.J. 2008. Orexin signaling mediates the antidepressant-like effect of calorie restriction. J Neurosci 28, 3071 3075.
52. Mair, R.G. Hembrook, J.R. 2008. Memory enhancement with event-related stimulation of the rostral intralaminar thalamic nuclei. J Neurosci 28, 14293 14300.
53. Marcus, J.N., Aschkenasi, C.J., Lee, C.E., Chemelli, R.M., Saper, C.B., Yanagisawa, M. Elmquist, J.K. 2001. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435, 6 25.
54. Matsuzaki, I., Sakurai, T., Kunii, K., Nakamura, T., Yanagisawa, M. Goto, K. 2002. Involvement of the serotonergic system in orexin-induced behavioral alterations in rats. Regul Pept 104, 119 123.
55. Muraki, Y., Yamanaka, A., Tsujino, N., Kilduff, T.S., Goto, K. Sakurai, T. 2004. Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor. J Neurosci 24, 7159 7166.
56. Murphy, J.A., Deurveilher, S. Semba, K. 2003. Stimulant doses of caffeine induce c-FOS activation in orexin/hypocretin-containing neurons in rat. Neuroscience 121, 269 275.
57. Nelson, L.E., Guo, T.Z., Lu, J., Saper, C.B., Franks, N.P. Maze, M. 2002. The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway. Nat Neurosci 5, 979 984.
58. Nishino, S., Fujiki, N., Ripley, B., Sakurai, E., Kato, M., Watanabe, T., Mignot, E. Yanai, K. 2001. Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs. Neurosci Lett 313, 125 128.
59. Nishino, S., Sakurai, E., Nevsimalova, S., Yoshida, Y., Watanabe, T., Yanai, K. Mignot, E. 2009. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls. Sleep 32, 175 180.
60. Overeem, S., van Vliet, J.A., Lammers, G.J., Zitman, F.G., Swaab, D.F. Ferrari, M.D. 2002. The hypothalamus in episodic brain disorders. Lancet Neurol 1, 437 444.
61. Parmentier, R., Ohtsu, H., Djebbara-Hannas, Z., Valatx, J.L., Watanabe, T. Lin, J.S. 2002. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 22, 7695 7711.
62. Parmentier, R., Kolbaev, S., Klyuch, B.P., Vandael, D., Lin, J.S., Selbach, O., Haas, H.L. Sergeeva, O.A. 2009. Excitation of histaminergic tuberomamillary neurons by thyrotropin-releasing hormone. J Neurosci 29, 4471 4483.
63. Petersen, A. Bjorkqvist, M. 2006. Hypothalamic-endocrine aspects in Huntington's disease. Eur J Neurosci 24, 961 967.
64. Peyron, C., Tighe, D.K., van den Pol, A.N., de Lecea, L., Heller, H.C., Sutcliffe, J.G. Kilduff, T.S. 1998. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18, 9996 10015.
65. van den Pol, A.N., Gao, X.B., Obrietan, K., Kilduff, T.S. Belousov, A.B. 1998. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci 18, 7962 7971.
66. van den Pol, A.N., Ghosh, P.K., Liu, R.J., Li, Y., Aghajanian, G.K. Gao, X.B. 2002. Hypocretin (orexin) enhances neuron activity and cell synchrony in developing mouse GFP-expressing locus coeruleus. J Physiol 541, 169 185.
67. Ponomarenko, A.A., Lin, J.S., Selbach, O. Haas, H.L. 2003. Temporal pattern of hippocampal high-frequency oscillations during sleep after stimulant-evoked waking. Neuroscience 121, 759 769.
68. Rao, Y., Liu, Z.W., Borok, E., Rabenstein, R.L., Shanabrough, M., Lu, M., Picciotto, M.R., Horvath, T.L. Gao, X.B. 2007. Prolonged wakefulness induces experience-dependent synaptic plasticity in mouse hypocretin/orexin neurons. J Clin Invest 117, 4022 4033.
69. Rinne, J.O., Anichtchik, O.V., Eriksson, K.S., Kaslin, J., Tuomisto, L., Kalimo, H., Roytta, M. Panula, P. 2002. Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy. J Neurochem 81, 954 960.
70. Rouet-Benzineb, P., Rouyer-Fessard, C., Jarry, A., Avondo, V., Pouzet, C., Yanagisawa, M., Laboisse, C., Laburthe, M. Voisin, T. 2004. Orexins acting at native OX(1) receptor in colon cancer and neuroblastoma cells or at recombinant OX(1) receptor suppress cell growth by inducing apoptosis. J Biol Chem 279, 45875 45886.
71. Russell, S.H., Kim, M.S., Small, C.J., Abbott, C.R., Morgan, D.G., Taheri, S., Murphy, K.G., Todd, J.F., Ghatei, M.A. Bloom, S.R. 2000. Central administration of orexin-A suppresses basal and domperidone stimulated plasma prolactin. J Neuroendocrinol 12, 1213 1218.
72. Sakurai, T. 2007. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 8, 171 181.
73. Salomon, R.M., Ripley, B., Kennedy, J.S., Johnson, B., Schmidt, D., Zeitzer, J.M., Nishino, S. Mignot, E. 2003. Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects. Biol Psychiatry 54, 96 104.
74. Samson, W.K., Taylor, M.M. Ferguson, A.V. 2005. Non-sleep effects of hypocretin/orexin. Sleep Med Rev 9, 243 252.
75. Saper, C.B., Scammell, T.E. Lu, J. 2005. Hypothalamic regulation of sleep and circadian rhythms. Nature 437, 1257 1263. (Pubitemid 41568665)
76. Scammell, T.E., Estabrooke, I.V., McCarthy, M.T., Chemelli, R.M., Yanagisawa, M., Miller, M.S. Saper, C.B. 2000. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 20, 8620 8628.
77. Selbach, O. Haas, H.L. 2006. Hypocretins: the timing of sleep and waking. Chronobiol Int 23, 63 70.
78. Selbach, O., Eriksson, K.S. Haas, H.L. 2003. Drugs to interfere with orexins (hypocretins). Drug News Perspect 16, 669 681.
79. Selbach, O., Doreulee, N., Bohla, C., Eriksson, K.S., Sergeeva, O.A., Poelchen, W., Brown, R.E. Haas, H.L. 2004. Orexins/hypocretins cause sharp wave- and theta-related synaptic plasticity in the hippocampus via glutamatergic, gabaergic, noradrenergic, and cholinergic signaling. Neuroscience 127, 519 528.
80. Sergeeva, O.A., Eriksson, K.S., Sharonova, I.N., Vorobjev, V.S. Haas, H.L. 2002. GABA(A) receptor heterogeneity in histaminergic neurons. Eur J Neurosci 16, 1472 1482.
81. Sergeeva, O.A., Amberger, B.T., Eriksson, K.S., Scherer, A. Haas, H.L. 2003a. Co-ordinated expression of 5-HT2C receptors with the NCX1 Na+/Ca2+ exchanger in histaminergic neurones. J Neurochem 87, 657 664.
82. Sergeeva, O.A., Korotkova, T.M., Scherer, A., Brown, R.E. Haas, H.L. 2003b. Co-expression of non-selective cation channels of the transient receptor potential canonical family in central aminergic neurones. J Neurochem 85, 1547 1552.
83. Sergeeva, O.A., Klyuch, B.P., Fleischer, W., Eriksson, K.S., Korotkova, T.M., Siebler, M. Haas, H.L. 2006. P2Y receptor-mediated excitation in the posterior hypothalamus. Eur J Neurosci 24, 1413 1426.
84. Sherin, J.E., Shiromani, P.J., McCarley, R.W. Saper, C.B. 1996. Activation of ventrolateral preoptic neurons during sleep. Science 271, 216 219.
85. Siegel, J.M. Boehmer, L.N. 2006. Narcolepsy and the hypocretin system - where motion meets emotion. Nat Clin Pract Neurol 2, 548 556.
86. + hematopoietic stem and progenitor cells express functionally active receptors of neuromediators. Blood 104, 81 88.
87. Stevens, D.R., Kuramasu, A., Eriksson, K.S., Selbach, O. Haas, H.L. 2004. Alpha 2-adrenergic receptor-mediated presynaptic inhibition of GABAergic IPSPs in rat histaminergic neurons. Neuropharmacology 46, 1018 1022.
88. Swanson, J.M. 2003. Role of executive function in ADHD. J Clin Psychiatry 64 (Suppl. 14 35 39.
89. Telegdy, G. Adamik, A. 2002. The action of orexin A on passive avoidance learning. Involvement of transmitters. Regul Pept 104, 105 110.
90. Thakkar, M.M., Engemann, S.C., Walsh, K.M. Sahota, P.K. 2008. Adenosine and the homeostatic control of sleep: effects of A1 receptor blockade in the perifornical lateral hypothalamus on sleep-wakefulness. Neuroscience 153, 875 880.
91. Torrealba, F., Yanagisawa, M. Saper, C.B. 2003. Colocalization of orexin-A and glutamate immunoreactivity in axon terminals in the tuberomammillary nucleus in rats. Neuroscience 119, 1033 1044.
92. Vyazovskiy, V.V., Cirelli, C., Pfister-Genskow, M., Faraguna, U. Tononi, G. 2008. Molecular and electrophysiological evidence for net synaptic potentiation in wake and depression in sleep. Nat Neurosci 11, 200 208.
93. Walling, S.G., Nutt, D.J., Lalies, M.D. Harley, C.W. 2004. Orexin-A infusion in the locus ceruleus triggers norepinephrine (NE) release and NE-induced long-term potentiation in the dentate gyrus. J Neurosci 24, 7421 7426.
94. Wayner, M.J., Armstrong, D.L., Phelix, C.F. Oomura, Y. 2004. Orexin-A (Hypocretin-1) and leptin enhance LTP in the dentate gyrus of rats in vivo. Peptides 25, 991 996.
95. Willie, J.T., Chemelli, R.M., Sinton, C.M. Yanagisawa, M. 2001. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci 24, 429 458.
96. Wollmann, G., Acuna-Goycolea, C. van den Pol, A.N. 2005. Direct excitation of hypocretin/orexin cells by extracellular ATP at P2X receptors. J Neurophysiol 94, 2195 2206.
97. Wu, M., Zhang, Z., Leranth, C., Xu, C., van den Pol, A.N. Alreja, M. 2002. Hypocretin increases impulse flow in the septohippocampal GABAergic pathway: implications for arousal via a mechanism of hippocampal disinhibition. J Neurosci 22, 7754 7765.
98. Yoshida, K., McCormack, S., Espana, R.A., Crocker, A. Scammell, T.E. 2006. Afferents to the orexin neurons of the rat brain. J Comp Neurol 494, 845 861.
99. Zeitzer, J.M., Nishino, S. Mignot, E. 2006. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions. Trends Pharmacol Sci 27, 368 374.